Complete expanded enrollment for the COSMIC-313 phase 3 trial
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Jan 2021
- Due
- 31 Mar 2021
- Delivered
- March 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“expects to complete the expanded enrollment in early 2021.”
What we found
Evidence strength A What the grades mean
The company completed the expanded enrollment for the COSMIC-313 phase 3 trial in March 2021, which falls within the early 2021 timeframe.
-
A Exelixis, Inc. 10-K filed 2022-02-18
“We completed the expanded enrollment of 855 patients in March 2021” ✓ confirmed on the page
Market reaction: the shares moved +9.3% against the S&P 500 over the three sessions around the disclosure (17 Feb 2022 to 23 Feb 2022). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- COSMIC-313 expanded enrollment
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Exelixis, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-EXEL-021420 · Corrections policy